Lessons learned from testicular cancer: Identification of cytoplasmic p21 as an Achilles' heel of cisplatin resistance

Cell Cycle

Volumn 9, Issue 24, 2010, Pages 4776-4777

  Koster, Roelof ^a   De Jong, Steven ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CISPLATIN; PROTEIN P21; TRICIRIBINE;

APOPTOSIS; CANCER RESISTANCE; CARCINOMA CELL; CELLULAR DISTRIBUTION; CYTOPLASM; EDITORIAL; EMBRYONAL CARCINOMA; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TESTIS CANCER;

EID: 78650320601     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.24.14247     Document Type: Editorial

References (11)

1. Oosterhuis JW, et al. Nat Rev Cancer 2005; 5:210-22.
2. Spierings DC, et al. Oncogene 2004; 23:4862-72.
3. di Pietro A, et al. Int J Biochem Cell Biol 2005; 37:2437-56.
4. Spierings DC, et al. Cell Death Differ 2003; 10:808-22.
5. Koster R, et al. J Clin Invest 2010; 120:3594-605.
6. Ivanovska I, et al. Mol Cell Biol 2008; 28:2167-74.
7. Marson A, et al. Cell 2008; 134:521-33.
8. Josephson R, et al. Stem Cells 2007; 25:437-46.
9. Xu N, et al. Cell 2009; 137:647-58.
10. Suzuki HI, et al. Nature 2009; 460:529-33.
11. Blagosklonny MV. Cell Cycle 2002; 1:391-3.